Received Oct 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
mild soreness at the injection site; This is a spontaneous report received from a Consumer or other non HCP. An 18-year-old female patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 12Oct2025 at 16:00 as dose 1, single (Batch/Lot number: unknown) at the age of 18 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 12Oct2025 at 22:00, outcome "unknown", described as "mild soreness at the injection site".; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202500121455 same reporter/drug/AE, Different patient;